Sign in

CIK 0001894562

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Prime Medicine, Inc.

Sign in to watch
Ticker
PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-465-0013
Business address
60 FIRST ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-23 Alenson Carman Grant or award · Stock Option (right to buy) +140,000 140,000
2025-08-01 Alenson Carman Returned to the company · Stock Option (right to buy) −16,083 0
2025-08-01 Alenson Carman Grant or award · Stock Option (right to buy) +16,083 16,083
2025-08-01 Alenson Carman Returned to the company · Stock Option (right to buy) −90,498 0
2025-08-01 Alenson Carman Grant or award · Stock Option (right to buy) +90,498 90,498
2025-08-01 Alenson Carman Returned to the company · Stock Option (right to buy) −6,254 0
2025-08-01 Alenson Carman Grant or award · Stock Option (right to buy) +6,254 6,254
2025-08-01 Alenson Carman Returned to the company · Stock Option (right to buy) −90,498 0
2025-08-01 Alenson Carman Grant or award · Stock Option (right to buy) +90,498 90,498
2025-02-27 Alenson Carman Grant or award · Stock Option (right to buy) +90,500 90,500
2024-02-21 Alenson Carman Grant or award · Stock Option (right to buy) +90,498 90,498
2023-04-18 Alenson Carman Grant or award · Stock Option (right to buy) +6,254 6,254
2023-03-31 Alenson Carman Grant or award · Stock Option (right to buy) +90,498 90,498

Page 1 of 1 · 13 trades